Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Metabolism and nutrition disorders – page 65

  • 776 clinical trials
  • 267 recruiting
  • 243 conditions
  • 26 countries

Conditions in this area

243 conditions with trials, the busiest first

Obesity131Type 2 diabetes mellitus95Overweight64Type 1 diabetes mellitus42Endocrine ophthalmopathy27Metabolic dysfunction-associated steatohepatitis24Diabetes mellitus21Non-alcoholic steatohepatitis17Diabetic retinal oedema15Type IIa hyperlipidaemia15Chronic kidney disease14Glycogen storage disease type II14Hypercholesterolaemia14Diabetic foot13Diabetic neuropathy13Alpha-1 antitrypsin deficiency11Fabry's disease10Hypoparathyroidism10Osteoporosis10Hypertriglyceridaemia9Acromegaly8Adrenoleukodystrophy8Dyslipidaemia8Glucose tolerance impaired8+219

Clinical trials in Metabolism and nutrition disorders

776 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

776 clinical trials

Hypocalcaemia+1

Not recruiting

Study on Preventing Low Calcium Levels After Thyroid Surgery with Preoperative Cholecalciferol Supplementation for Patients Undergoing Total Thyroidectomy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Colecalciferol
  • Sponsor:Hopital NOVO

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Orion Corporation

Primary hypercholesterolaemia

Not recruiting

Study on Managing High Cholesterol in Cardiovascular Disease Patients Using Inclisiran

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Semmelweis University

Adrenoleukodystrophy

Not recruiting

Study on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leriglitazone
  • Sponsor:Minoryx Therapeutics S.L.

Type 1 diabetes mellitus

Not recruiting

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ixekizumab
  • Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Endocrine ophthalmopathy

Not recruiting

Study on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-001
  • Sponsor:Viridian Therapeutics Inc.

Niemann-Pick disease

Not recruiting

Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Miglustat
  • Sponsor:Cyclo Therapeutics Inc.

Diabetic retinal oedema

Not recruiting

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Substances studied in this area

The therapies tested most often in Metabolism and nutrition disorders trials.

Semaglutide81 clinical trialsSodium Chloride26 clinical trialsDapagliflozin24 clinical trialsTirzepatide20 clinical trialsEmpagliflozin16 clinical trialsCagrilintide15 clinical trialsColecalciferol14 clinical trialsPlacebo14 clinical trialsZenagamtide14 clinical trials
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.